Medtronic Neuromodulation recalls A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
- Products
-
- A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.
- Company
- Medtronic Neuromodulation
- Where it was sold
-
Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.
Nationwide
- Barcodes
00763000632793- Units affected
- 4365 units
- About this recall
- A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.